Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Services
High ThroughputPARP in vivo Pharmacodynamic Assay
Monday, February 23, 2015
AMSBIO has introduced a unique High Throughput PARP in vivo Pharmacodynamic Assay that can be used to monitor the efficacy of poly-ADP-ribose polymerase (PARP) inhibitors on PAR formation in vivo; and to measure drug action on PARP in both in vivo and in vitro settings.
Vetter Development Service Chicago is Now Ready for Realizing Clinical Syringe Projects
Friday, December 12, 2014
Recent facility expansion offers new manufacturing options and additional filling capacity.
Imperial Innovations Leads £50 Million Series B Funding Round in Cell Medica
Tuesday, November 25, 2014
Cell Medica will use the investment capital to progress further the development of cellular immunotherapy products.
Clustering Effect Translates into Major Growth for BioPharma Specialist
Saturday, October 25, 2014
Company manages translation and linguistic validation projects.
New Accessories for the Mastersizer 3000 from Malvern Instruments
Friday, October 17, 2014
New accessories support smarter pharmaceutical particle size analysis.
FUJIFILM Diosynth Biotechnologies Announces the Launch of ‘Apollo™’
Thursday, October 09, 2014
New mammalian expression platform designed to create a robust ‘manufacturing-ready’ cell line.
The Lancet: Remote Monitoring Can Save ICD and CRT-D Patients' Lives
Tuesday, August 19, 2014
BIOTRONIK Home Monitoring reduces mortality and improves clinical outcomes in patients with heart failure.
Eurofins Genomics Adds NGS to ISO17025 Accredited Testing Portfolio
Saturday, August 16, 2014
ISO17025 accreditation to consistently offer valid results for testing in the fields of veterinary medicine, pharmaceuticals, food and animal feed, commodities and health care.
BD BACTEC FX40 Blood Culture Instrument Now Communicates with the BD EpiCenter Data Management System
Saturday, June 14, 2014
Low-Volume Clinical Laboratories Now Have Access to Advanced Data Management with New Blood Culture Instrument Connectivity
Showing Results 21 - 30 of 318
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,900+ scientific and medical posters
4,200+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!